Related Experiment Video
Updated: Dec 26, 2025
Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria
Published on: May 8, 2013
Structure-based discovery of a small-molecule inhibitor of methicillin-resistant Staphylococcus aureus virulence
Jie Liu1, Lina Kozhaya2, Victor J Torres3
1Public Health Research Institute, Department of Microbiology, Biochemistry, and Molecular Genetics, New Jersey Medical School, Rutgers University, Newark, New Jersey 07103.
Abstract:
The rapid emergence and dissemination of methicillin-resistant Staphylococcus aureus (MRSA) strains poses a major threat to public health. MRSA possesses an arsenal of secreted host-damaging virulence factors that mediate pathogenicity and blunt immune defenses. Panton-Valentine leukocidin (PVL) and α-toxin are exotoxins that create lytic pores in the host cell membrane. They are recognized as being important for the development of invasive MRSA infections and are thus potential targets for antivirulence therapies. Here, we report the high-resolution X-ray crystal structures of both PVL and α-toxin in their soluble, monomeric, and oligomeric membrane-inserted pore states in complex with n-tetradecylphosphocholine (C14PC). The structures revealed two evolutionarily conserved phosphatidylcholine-binding mechanisms and their roles in modulating host cell attachment, oligomer assembly, and membrane perforation. Moreover, we demonstrate that the soluble C14PC compound protects primary human immune cells in vitro against cytolysis by PVL and α-toxin and hence may serve as the basis for the development of an antivirulence agent for managing MRSA infections.
Insights
Researchers determined the structures of Panton-Valentine leukocidin (PVL) and α-toxin from MRSA. A compound, C14PC, was found to protect immune cells from these toxins, offering potential for new MRSA infection treatments.
Area of Science:
- Microbiology
- Structural Biology
- Immunology
Background:
- Methicillin-resistant Staphylococcus aureus (MRSA) is a significant public health threat due to its virulence factors.
- Panton-Valentine leukocidin (PVL) and α-toxin are key MRSA exotoxins that damage host cells by forming pores.
- These toxins are crucial for invasive MRSA infections, making them targets for antivirulence therapies.
Purpose of the Study:
- To determine the high-resolution X-ray crystal structures of PVL and α-toxin.
- To elucidate the mechanisms of host cell interaction and membrane pore formation.
- To evaluate the potential of a compound as an antivirulence agent against MRSA toxins.
Main Methods:
- High-resolution X-ray crystallography of PVL and α-toxin in soluble and membrane-inserted states.
- Complexation with n-tetradecylphosphocholine (C14PC) to stabilize structures.
- In vitro assays using primary human immune cells to assess protection against toxin-induced cytolysis.
Main Results:
- Determined the structures of PVL and α-toxin, revealing conserved phosphatidylcholine-binding mechanisms.
- Identified roles of these mechanisms in host cell attachment, oligomer assembly, and membrane perforation.
- Demonstrated that soluble C14PC protects human immune cells from PVL and α-toxin cytolysis.
Conclusions:
- The structural insights into PVL and α-toxin provide a basis for understanding their pathogenicity.
- The identified phosphatidylcholine-binding mechanisms are critical for toxin function.
- Soluble C14PC shows promise as a therapeutic agent to combat MRSA infections by neutralizing key toxins.
